NCT03694808View on ClinicalTrials.gov

FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care

PHASE4CompletedINTERVENTIONAL
Enrollment

478

Participants

Timeline

Start Date

September 23, 2018

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Flu
Interventions
DRUG

Fluad Vaccine

single adjuvanted dose (AD) intramuscular injection

DRUG

Fluzone HD Vaccine

single high dose (HD) intramuscular injection

Trial Locations (2)

44106

Louis Stokes Cleveland VA Medical Center, Cleveland

University Hospitals Cleveland Medical Center, Cleveland

Sponsors

Collaborators (1)

Brown University
All Listed Sponsors
collaborator

Case Western Reserve University

OTHER

collaborator

US Department of Veterans Affairs

FED

collaborator

Brown University

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

David H. Canaday

OTHER

NCT03694808 - FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care | Biotech Hunter | Biotech Hunter